Abstract:OBJECTIVE:Recently a formulation of intravenous (IV) ibuprofen was developed in China for management of mild to moderate pain in patients who could not take oral medications or where intravenous administration was preferable. The aim of this study was to evaluate the pharmacokinetic properties and tolerability of single and multiple doses of ibuprofen injection in healthy Chinese volunteers.METHODS:This open-label, single- and multiple-dose study was conducted in healthy Chinese volunteers. In the single-dose phase, subjects were randomized to receive a single dose of ibuprofen injection 0.2, 0.4, or 0.8 g administered as a 30-minute IV infusion with a 1-week washout between periods. Blood samples were collected at regular intervals from 0 to 12.5 hours after drug administration and were analyzed using a validated LC-MS/MS method. In the multiple-dose phase, subjects received 0.4 g ibuprofen every 6 hours for 9 doses. Blood samples were obtained before the 7th, 8th, and 9th administration to determine the Cmin at steady state; on the 9th intravenous administration, blood samples were also collected for 12.5 hours after drug administration. Pharmacokinetic parameters were estimated using a noncompartmental model. Tolerability was determined using clinical evaluation and monitoring of adverse events (AEs).RESULTS:A total of 12 healthy male (n = 6) and female (n = 6) Chinese volunteers were enrolled and completed the trial. After IV administration of single dose, the mean (SD) Cmax value increased from 35.77 (6.98) to 117.12 (19.78) µg/mL, and the mean (SD) AUC0-t value increased from 67.63 (10.30) to 230.50 (33.55) µg×h/mL in the range of 0.2-g to 0.8-g dose. The terminal half-life in plasma was ~ 2.0 hours. After IV administration of 9 doses of ibuprofen 400 mg every 6 hours, the mean (SD) Cmax was 66.49 (8.49) µg/mL, the AUC0-t was 135.65 (26.91) µg×h/mL, the t1/2 was 2.14 (0.34) hours, the Cl/F was 3.34 (0.68) L/h, and the Vz/F was 10.32 (2.69) L, which were comparable with those after single dosing. The accumulation index was 1.17 (0.06), and the fluctuation was 304.0 (57.7) %. Results of the t-tests of Cmax and AUC found no significant differences between the male and female groups. No serious AEs were reported, and there were no discontinuations due to AEs.CONCLUSION:The pharmacokinetics of ibuprofen exhibited dose-related kinetics from the 0.2- to the 0.8-g dose. After multiple doses, the pharmacokinetic parameters of ibuprofen were consistent with those after single doses. There was no accumulation in ibuprofen exposure in healthy Chinese between multiple doses and single dose. At the doses studied, ibuprofen appeared to be well tolerated in these healthy volunteers. .

Studies on the pharmacokinetics of isosorbide dinitrate (ISDN) injection in healthy volunteers

Pharmacokinetics of Three Organic Nitrates in Chinese Healthy Male Volunteers

A Simple Blood Microdialysis in Freely-Moving Rats for Pharmacokinetic–pharmacodynamic Modeling Study of Shengmai Injection with Simultaneous Determination of Drug Concentrations and Efficacy Levels in Dialysate

Double-Blind, Multicenter, Active-Controlled, Randomized Clinical Trial to Assess the Safety and Efficacy of Orally Administered Nicorandil in Patients with Stable Angina Pectoris in China

Pharmacokinetics of Ginsenosides Rg1, Re and Notoginsenoside R1 in Rats by an in vivo Microdialysis Coupled with Liquid Chromatography/Mass Spectrometry

Pharmacokinetics of Domestic and Imported Isosorbide Mononitrate Sustained-Release Capsule Following a Single and Multiple Dose in Healthy Volunteers

Pharmacokinetics, Tissue Distribution and Excretion of Saponins after Intravenous Administration of ShenMai Injection in Rats.

Pharmacokinetics and Bioavailability Study of Danshensu in Rat

A Novel Transdermal Patch Incorporating Isosorbide Dinitrate with Bisoprolol: in Vitro and in Vivo Characterization.

Studies on Preparation and in Vitro Evaluation of Isosorbide Dinitrate Solid Dispersion

Quality analysis of three isosorbide nitrate intravenous injections

Renal Tolerability of Iopromide and Iodixanol in 562 Renally Impaired Patients Undergoing Cardiac Catheterisation: the Direct Study

Study on PK-PD characteristics of ginsenoside Rg1 and Rb1, in rats with myocardial ischemia following intravenous administration of shengmai injection]

Comparison of Relative Bioavailability of Three Kinds of Isosorbide Mononitrate Sustained-Release Preparations

Improved GC for Isosorbide-5-mononitrate Determination in Dog Plasma and Its Application in Pharmacokinetics

Cohort Study on Therapeutic Efficacy of SXT and SXN Injection in the Treatment of Acute Ischemic Stroke

Study on the Pharmacokinetics and Bioequivalence of Isosorbide 5-Mononitrate and Aspirin from Compound Isosorbide Mononitrate Sustained Release Tablets in Healthy Volunteers

Pharmacokinetics and Tolerability of Intravenous Ibuprofen Injection in Healthy Chinese Volunteers: a Randomized, Open-Label, Single- and Multiple-Dose Study

Efficacy of Suxiaojiuxinwan vs. Isosorbide Dinitratein patients with angina pectoris：a meta-analysis

Pharmacokinetics of sodium aescinate for injection in healthy volunteers

Efficacy of add-on Danhong injection in patients with unstable angina pectoris: A double-blind, randomized, placebo-controlled, multicenter clinical trial